Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 132 shares at $84.55 ($11K) on 2022-04-16, disclosed to the SEC on 2022-04-19.
Seasonal sale ($11k) by SVP, Chief Accounting Officer — this insider has traded RARE in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| RARE | SELL | 2026-03-03 | $37K | — | Filing → |
| RARE | SELL | 2025-12-30 | $3K | — | Filing → |
| RARE | SELL | 2025-09-19 | $2K | — | Filing → |